Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer

Abstract

This work presents direct evidence that the bcl-2 gene is transcriptionally regulated by nuclear factor-κB (NF-κB) and directly links the TNF-α/NF-κB signaling pathway with Bcl-2 expression and its pro-survival response in human prostate carcinoma cells. DNase I footprinting, gel retardation and supershift analysis identified a NF-κB site in the bcl-2 p2 promoter. In the context of a minimal promoter, this bcl-2 p2 site 1 increased transcription 10-fold in the presence of the p50/p65 expression vectors, comparable to the increment observed with the consensus NF-κB site, while for the full p2 promoter region transcriptional activity was increased sixfold by over-expression of NF-κB, an effect eliminated by mutating the bcl-2 p2 site 1. The expression of Bcl-2 has been linked to the hormone-resistant phenotype of advanced prostate cancer. Here we show that an increase in the level of expression of Bcl-2 in the human prostate carcinoma cell line LNCaP observed in response to hormone withdrawal is further augmented by TNF-α treatment, and this effect is abated by inhibitors of NF-κB. Concomitantly, bcl-2 p2 promoter studies in LNCaP cells show a 40-fold increase in promoter activity after stimulation with TNF-α in the absence of hormone.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Apakama I, Robinson MC, Walter NM, Charlton RG, Royds JA, Fuller CE, Neal DE, Hamdy FC . 1996 Br. J. Cancer 74: 1258–1262

  • Arsura M, Wu M, Sonenshein GE . 1996 Immunity 5: 31–40

  • Baeuerle PA . 1991 Biochim. Biophys. Acta 1072: 63–80

  • Baeuerle PA, Baltimore D . 1996 Cell 87: 13–20

  • Baeuerle PA, Henkel T . 1994 Annu. Rev. Immunol. 12: 141–179

  • Baldwin Jr AS . 1996 Annu. Rev. Immunol. 14: 649–683

  • Baltaci S, Orhan D, Ozer G, Tolunay O, Gogous O . 2000 BJU. Int. 85: 155–159

  • Beg AA, Baltimore D . 1996 Science 274: 782–784

  • Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D . 1995 Nature 376: 167–170

  • Briggs MR, Kadonaga JT, Bell SP, Tjian R . 1986 Science 234: 47–52

  • Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP . 1996 Nat. Med. 2: 788–794

  • Bubendorf L, Sauter G, Moch H, Jordan P, Blochlinger A, Gasser TC, Mihatsch MJ . 1996 Am. J. Pathol. 148: 1557–1565

  • Camandola S, Mattson MP . 2000 J. Neurosci. Res. 61: 134–139

  • Chaudhary KS, Abel PD, Lalani EN . 1999 Environ. Health Perspect. 107: Suppl 1 49–57

  • Chen HM, Boxer LM . 1995 Mol. Cell Biol. 15: 3840–3847

  • Cheng B, Christakos S, Mattson MP . 1994 Neuron 12: 139–153

  • Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW . 1997 Proc. Natl. Acad. Sci. USA 94: 10057–10062

  • Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R . 1993 Am. J. Pathol. 143: 390–400

  • de Moissac D, Mustapha S, Greenberg AH, Kirshenbaum LA . 1998 J. Biol. Chem. 273: 23946–23951

  • de Moissac D, Zheng H, Kirshenbaum LA . 1999 J. Biol. Chem. 274: 29505–29509

  • Dignam JD, Lebovitz RM, Roeder RG . 1983 Nucleic. Acids. Res. 11: 1475–1489

  • Frampton J, Ramqvist T, Graf T . 1996 Genes Dev. 10: 2720–2731

  • Graham FL, van der Eb AJ . 1973 Virology 52: 456–467

  • Grilli M, Chiu JJ, Lenardo MJ . 1993 Int. Rev. Cytol. 143: 1–62

  • Gross A, McDonnell JM, Korsmeyer SJ . 1999 Genes Dev. 13: 1899–1911

  • Heckman C, Mochon E, Arcinas M, Boxer LM . 1997 J. Biol. Chem. 272: 19609–19614

  • Herrmann JL, Beham AW, Sarkiss M, Chaio PJ, Rands MT, Bruckheimer EM, Brisbay S, McDonnell TJ . 1997 Exp. Cell Res. 237: 101–109

  • Hewitt SM, Hamada S, McDonnell TJ, Rauscher FJ, Saunders GF . 1995 Cancer Res. 55: 5386–5389

  • Huang A, Gandour-Edwards R, Rosenthal SA, Siders DB, Deitch AD, White RW . 1998 Urology 51: 346–351

  • Jacobs MD, Harrison SC . 1998 Cell 95: 749–758

  • Johnson JL, McLachlan A . 1994 Nucleic. Acids. Res. 22: 5085–5092

  • Johnson JL, Raney AK, McLachlan A . 1995 Virology 208: 147–158

  • Karin M . 1999 J. Biol. Chem. 274: 27339–27342

  • Lenardo MJ, Baltimore D . 1989 Cell 58: 227–229

  • Liou HC, Baltimore D . 1993 Curr. Opin. Cell Biol. 5: 477–487

  • Liu ZG, Hsu H, Goeddel DV, Karin M . 1996 Cell 87: 565–576

  • Lu S, Tsai SY, Tsai MJ . 1999 Endocrinology 140: 5054–5059

  • Mackey TJ, Borkowski A, Amin P, Jacobs SC, Kyprianou N . 1998 Urology 52: 1085–1090

  • Mattson MP, Goodman Y, Luo H, Fu W, Furukawa K . 1997 J. Neurosci. Res. 49: 681–697

  • McCormack JE, Pepe VH, Kent RB, Dean M, Marshak-Rothstein A, Sonenshein GE . 1984 Proc. Natl. Acad. Sci. USA 81: 5546–5550

  • McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh, JT, Tu SM,, Campbell ML . 1992 Cancer Res. 52: 6940–6944

  • Miyake H, Hanada N, Nakamura H, Kagawa S, Fujiwara T, Hara I, Eto H, Gohji K, Arakawa S, Kamidono S, Saya H . 1998 Oncogene 16: 933–943

  • Miyashita T, Harigai M, Hanada M, Reed JC . 1994 Cancer Res. 54: 3131–3135

  • Miyashita T, Reed JC . 1995 Cell 80: 293–299

  • Nabel G, Baltimore D . 1987 Nature 326: 711–713

  • Nabel GJ, Verma IM . 1993 Genes Dev. 7: 2063

  • Nakashima J, Tachibana M, Ueno M, Miyajima A, Baba S, Murai M . 1998 Clin. Cancer Res. 4: 1743–1748

  • Oltvai ZN, Korsmeyer SJ . 1994 Cell 79: 189–192

  • Oltvai ZN, Milliman CL, Korsmeyer SJ . 1993 Cell 74: 609–619

  • Perlman H, Zhang X, Chen MW, Walsh K, Buttyan R . 1999 Cell Death. Differ. 6: 48–54

  • Prösch S, Staak K, Stein J, Liebenthal C, Stamminger T, Hans-Dieter V, Krüger DH . 2000 Virology 208: 197–206

  • Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R . 1995 Cancer Res. 55: 4438–4445

  • Saeed B, Zhang H, Ng SC . 1997 Prostate 31: 145–152

  • Sambrook J, Maniatis T, Fritsch EF . 1989 Molecular cloning: a laboratory manual, 2nd edition Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York

  • Sanger F, Nicklen S, Coulson AR . 1977 Proc. Natl. Acad. Sci. USA 74: 5463–5467

  • Scherr DS, Vaughan Jr ED, Wei J, Chung M, Felsen D, Allbright R, Knudsen BS . 1999 J. Urol. 162: 12–16

  • Sen R, Baltimore D . 1986 Cell 46: 705–716

  • Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P, Korsmeyer SJ . 1988 EMBO J. 7: 123–131

  • Sinha AA, Blackard CE, Seal US . 1977 Cancer 40: 2836–2850

  • Smith MD, Ensor EA, Coffin RS, Boxer LM, Latchman DS . 1998 J. Biol. Chem. 273: 16715–16722

  • Sorge J, Wright D, Erdman VD, Cutting AE . 1984 Mol. Cell Biol. 4: 1730–1737

  • Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J . 1998 J. Exp. Med. 188: 211–216

  • Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyaka S, Mizuno T, Tohyama M . 1999 J. Biol. Chem. 274: 8531–8538

  • Taylor D, Badiani P, Weston K . 1996 Genes Dev. 10: 2732–2744

  • Thanos D, Maniatis T . 1995 Mol. Cell Biol. 15: 152–164

  • Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM . 1996 Science 274: 787–789

  • Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S . 1995 Genes Dev. 9: 2723–2735

  • Virbasius CA, Virbasius JV, Scarpulla RC . 1993 Genes Dev. 7: 2431–2445

  • Wang CY, Guttridge DC, Mayo MW, Baldwin Jr AS . 1999a Mol. Cell Biol. 19: 5923–5929

  • Wang CY, Mayo MW, Baldwin ASJ . 1996 Science 274: 784–787

  • Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS . 1998 Science 281: 1680–1683

  • Wang Z, Morris GF, Reed JC, Kelly GD, Morris CB . 1999b Virology 257: 502–510

  • Westin P, Bergh A . 1998 Cancer Detect. Prev. 22: 476–484

  • Wilson BE, Mochon E, Boxer LM . 1996 Mol. Cell Biol. 16: 5546–5556

  • Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sher DH, Sonenshein GE . 1996 EMBO J. 15: 4682–4690

  • Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF . 1998 Science 281: 998–1001

  • You M, Ku PT, Hrdlickova R, Bose Jr HR . 1997 Mol. Cell Biol. 17: 7328–7341

  • Young RL, Korsmeyer SJ . 1993 Mol. Cell Biol. 13: 3686–3697

  • Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C . 1999 Genes Dev. 13: 382–387

  • Zou H, Henzel WJ, Liu X, Lutschg A, Wang X . 1997 Cell 90: 405–413

Download references

Acknowledgements

This work was supported in part by USPHS grant AI-44434, the Stein Endowment Fund, and the Skaggs training grant. We wish to thank Julie M Ruedi for technical assistance and Carol Fedoryszyn for help with the preparation of this manuscript. PC Atterton supplied technical writing services.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jennifer L Johnson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Catz, S., Johnson, J. Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer. Oncogene 20, 7342–7351 (2001). https://doi.org/10.1038/sj.onc.1204926

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204926

Keywords

This article is cited by

Search

Quick links